Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anatol Kontush

Showing results (31-40 of 135) with videos related to

Pageof 14
Sort By:
Seminars in Vascular Medicine|October 13, 2004
High-density lipoprotein as a key component in the prevention of premature atherosclerotic disease in the insulin resistance syndromeBoris Hansel, Anatol Kontush, Marcel Th B Twickler
Biofactors (Oxford, England)|March 27, 2015
HDL particle subpopulations: Focus on biological functionFabiana H Rached, M John Chapman, Anatol Kontush
Current Pharmaceutical Design|November 2, 2016
HDL-Targeting Therapeutics: Past, Present and FutureEmile Zakiev, Ma Feng, Vasily Sukhorukov, et al.
Neurochemical Research|August 11, 2012
Effect of one-year vitamin C- and E-supplementation on cerebrospinal fluid oxidation parameters and clinical course in Alzheimer's diseaseSönke Arlt, Tomas Müller-Thomsen, Ulrike Beisiegel, et al.
Cardiology Clinics|April 4, 2018
Impact of Lipoproteins on Atherobiology: Emerging InsightsMa Feng, Fabiana Rached, Anatol Kontush, et al.
European Heart Journal|October 15, 2009
Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitorsM John Chapman, Wilfried Le Goff, Maryse Guerin, et al.
Metabolites|February 25, 2023
Capacity of HDL to Efflux Cellular Cholesterol from Lipid-Loaded Macrophages Is Reduced in Patients with Familial HypercholesterolemiaShiva Ganjali, Susan Hosseini, Manfredi Rizzo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2004
Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical propertiesAnatol Kontush, Eliana Cotta de Faria, Sandrine Chantepie, et al.
Atherosclerosis|September 15, 2005
A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activityAnatol Kontush, Eliana Cotta de Faria, Sandrine Chantepie, et al.
Archives of Biochemistry and Biophysics|May 26, 2009
Distinct HDL subclasses present similar intrinsic susceptibility to oxidation by HOClSandrine Chantepie, Ernst Malle, Wolfgang Sattler, et al.
Pageof 14

Showing results (31-40 of 135) with videos related to

Sort By:
Pageof 14
Seminars in Vascular Medicine|October 13, 2004
High-density lipoprotein as a key component in the prevention of premature atherosclerotic disease in the insulin resistance syndromeBoris Hansel, Anatol Kontush, Marcel Th B Twickler
Biofactors (Oxford, England)|March 27, 2015
HDL particle subpopulations: Focus on biological functionFabiana H Rached, M John Chapman, Anatol Kontush
Current Pharmaceutical Design|November 2, 2016
HDL-Targeting Therapeutics: Past, Present and FutureEmile Zakiev, Ma Feng, Vasily Sukhorukov, et al.
Neurochemical Research|August 11, 2012
Effect of one-year vitamin C- and E-supplementation on cerebrospinal fluid oxidation parameters and clinical course in Alzheimer's diseaseSönke Arlt, Tomas Müller-Thomsen, Ulrike Beisiegel, et al.
Cardiology Clinics|April 4, 2018
Impact of Lipoproteins on Atherobiology: Emerging InsightsMa Feng, Fabiana Rached, Anatol Kontush, et al.
European Heart Journal|October 15, 2009
Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitorsM John Chapman, Wilfried Le Goff, Maryse Guerin, et al.
Metabolites|February 25, 2023
Capacity of HDL to Efflux Cellular Cholesterol from Lipid-Loaded Macrophages Is Reduced in Patients with Familial HypercholesterolemiaShiva Ganjali, Susan Hosseini, Manfredi Rizzo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2004
Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical propertiesAnatol Kontush, Eliana Cotta de Faria, Sandrine Chantepie, et al.
Atherosclerosis|September 15, 2005
A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activityAnatol Kontush, Eliana Cotta de Faria, Sandrine Chantepie, et al.
Archives of Biochemistry and Biophysics|May 26, 2009
Distinct HDL subclasses present similar intrinsic susceptibility to oxidation by HOClSandrine Chantepie, Ernst Malle, Wolfgang Sattler, et al.
Pageof 14